WELL Health Technologies Corp. Receives Management Cease Trade Order from BCSC

WELL Health Technologies Corp. Receives MCTO

WELL Health Technologies Corp., a leading digital healthcare provider, has announced that it has received a Management Cease Trade Order (MCTO) from the British Columbia Securities Commission (BCSC). The order pertains to the company's delay in submitting its annual information form, audited annual financial statements, and management's discussion and analysis for the fiscal year ending December 31, 2024.

The MCTO was granted as part of WELL Health's proactive approach to address the issue of delayed filings. The BCSC's decision restricts both the Chief Executive Officer and Chief Financial Officer from trading any securities of the company until the required filings are completed. Importantly, this order does not restrict the trading of the company’s securities by shareholders who are not insiders, ensuring that public investors retain certain rights during this period.

In compliance with the MCTO, WELL Health has taken measures to uphold transparency, committing to provide bi-weekly default status updates through news releases. These updates will give relevant information to stakeholders regarding the company’s efforts to resolve the delay in the filings.

The underlining causes of the delay were already communicated in a previous announcement dated March 28, 2025. WELL Health Technologies Corp. is diligently working to finalize and file the pending documents as swiftly as possible.

This recent development underscores WELL Health's mission to enhance healthcare delivery by utilizing cutting-edge technology. The company is dedicated to empowering healthcare practitioners and patients by offering robust software solutions that streamline both front and back-office operations. This capability enables over 41,000 healthcare providers across the U.S. and Canada to provide better care outcomes.

With a wide reach that includes over 200 clinics in Canada focused on primary care, specialized care, and diagnostic services, WELL Health's influence in the healthcare ecosystem is significant. Its services extend into specialized markets in the U.S. as well, addressing needs in fields such as gastrointestinal health, women's health, primary care, and mental health.

As WELL Health Technologies continues to navigate this challenge, stakeholders can remain assured of the company's commitment to complying with regulatory requirements and improving the overall healthcare experience.

WELL Health remains publicly traded on the Toronto Stock Exchange under the ticker symbol `WELL` and also on the OTC Exchange with the symbol `WHTCF`. Further updates regarding the filings will be shared as developments occur, and interested parties are encouraged to visit www.well.company for additional information.

Conclusion

The MCTO by the BCSC is a pivotal moment for WELL Health as it confronts its operational challenges while striving to maintain confidence among investors and the public. The health technology firm’s dedication to innovative healthcare solutions remains unabated, even during regulatory hurdles.